Veradigm Inc. (NASDAQ:MDRX) Receives Consensus Rating of “Hold” from Brokerages

Veradigm Inc. (NASDAQ:MDRX) has been given an average recommendation of “Hold” by the five brokerages that are currently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $11.25.

Several equities research analysts recently weighed in on MDRX shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $10.00 price target (down from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Royal Bank of Canada lowered their price objective on Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a research note on Friday, January 19th. StockNews.com started coverage on shares of Veradigm in a research report on Monday. They set a “hold” rating for the company. Finally, Barclays began coverage on Veradigm in a report on Wednesday, January 3rd. They set an “equal weight” rating and a $11.00 price target on the stock.

Hedge Funds Weigh In On Veradigm

Institutional investors and hedge funds have recently made changes to their positions in the business. Quarry LP bought a new stake in Veradigm during the first quarter valued at about $37,000. Advisor Group Holdings Inc. boosted its holdings in Veradigm by 15.6% in the 4th quarter. Advisor Group Holdings Inc. now owns 4,833 shares of the software maker’s stock worth $85,000 after buying an additional 651 shares during the period. TFO Wealth Partners LLC boosted its stake in shares of Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after acquiring an additional 5,264 shares during the period. Tower Research Capital LLC TRC grew its position in shares of Veradigm by 95.0% during the second quarter. Tower Research Capital LLC TRC now owns 5,310 shares of the software maker’s stock worth $67,000 after purchasing an additional 2,587 shares in the last quarter. Finally, Gladius Capital Management LP raised its stake in Veradigm by 135.0% during the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock valued at $66,000 after purchasing an additional 3,587 shares during the period.

Veradigm Price Performance

Veradigm stock opened at $7.55 on Friday. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $14.09. The stock’s 50 day simple moving average is $7.81 and its two-hundred day simple moving average is $10.16.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.